|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
WO2014117121A1
(en)
|
2013-01-28 |
2014-07-31 |
St. Jude Children's Research Hospital, Inc. |
A chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease
|
|
US9725710B2
(en)
|
2014-01-08 |
2017-08-08 |
Flodesign Sonics, Inc. |
Acoustophoresis device with dual acoustophoretic chamber
|
|
KR20210014210A
(ko)
|
2014-05-15 |
2021-02-08 |
내셔널 유니버시티 오브 싱가포르 |
변형된 천연 살해 세포 및 그의 용도
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
EP3184548A1
(en)
*
|
2015-12-23 |
2017-06-28 |
Miltenyi Biotec GmbH |
Chimeric antigen receptor with cytokine receptor activating or blocking domain
|
|
CN109715808A
(zh)
*
|
2016-04-15 |
2019-05-03 |
诺华股份有限公司 |
用于选择性蛋白质表达的组合物和方法
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
WO2018169948A1
(en)
|
2017-03-13 |
2018-09-20 |
Poseida Therapeutics, Inc. |
Compositions and methods for selective elimination and replacement of hematopoietic stem cells
|
|
CA3056439A1
(en)
|
2017-03-27 |
2018-10-04 |
National University Of Singapore |
Truncated nkg2d chimeric receptors and uses thereof in natural killer cell immunotherapy
|
|
AU2018245749A1
(en)
|
2017-03-27 |
2019-10-03 |
National University Of Singapore |
Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
|
|
JOP20180027A1
(ar)
*
|
2017-03-28 |
2019-01-30 |
Cell Design Labs Inc |
بوليبيبتيدات مخلطة و طرق لتغيير موضع الغشاء فيها
|
|
US20230192839A1
(en)
*
|
2017-04-12 |
2023-06-22 |
Pfizer Inc. |
Antibodies having conditional affinity and methods of use thereof
|
|
CA3063719A1
(en)
*
|
2017-05-19 |
2018-11-22 |
The Regents Of The University Of California |
Antibody chemically induced dimerizer (abcid) as molecular switches for regulating cellular therapies
|
|
WO2019010201A1
(en)
*
|
2017-07-03 |
2019-01-10 |
Yale University |
REGULATED SMALL MOLECULE ADAPTER
|
|
CN107312797B
(zh)
*
|
2017-07-28 |
2021-06-18 |
广州中科蓝华生物科技有限公司 |
一种蛋白调控系统及其制备方法和应用
|
|
CA3076337A1
(en)
|
2017-09-19 |
2019-03-28 |
Massachusetts Institute Of Technology |
Compositions for chimeric antigen receptor t cell therapy and uses thereof
|
|
US11999802B2
(en)
|
2017-10-18 |
2024-06-04 |
Novartis Ag |
Compositions and methods for selective protein degradation
|
|
EP3723787A4
(en)
*
|
2017-12-14 |
2021-09-01 |
Bluebird Bio, Inc. |
DARIC INTERLEUKIN RECEPTORS
|
|
RU2020122708A
(ru)
*
|
2017-12-14 |
2022-01-14 |
2севэнти био, Инк. |
Рецепторы nkg2d daric
|
|
JP2021507561A
(ja)
|
2017-12-14 |
2021-02-22 |
フロデザイン ソニックス， インク．Ｆｌｏｄｅｓｉｇｎ Ｓｏｎｉｃｓ， Ｉｎｃ． |
音響トランスデューサドライバ及びコントローラ
|
|
EP3502130A1
(en)
|
2017-12-20 |
2019-06-26 |
St. Anna Kinderkrebsforschung |
Ligand regulated protein-protein interaction system
|
|
KR20200101942A
(ko)
|
2017-12-20 |
2020-08-28 |
세인트 안나 킨더크렙스포르슝 |
리간드 조절 단백질-단백질 상호작용 시스템
|
|
SG11202007156QA
(en)
|
2018-02-09 |
2020-08-28 |
Nat Univ Singapore |
Activating chimeric receptors and uses thereof in natural killer cell immunotherapy
|
|
EP3757133A4
(en)
|
2018-02-11 |
2021-12-01 |
Jiangsu Hengrui Medicine Co., Ltd. |
ISOLATED ANTIGENIC CHEMICAL RECEPTOR, MODIFIED T LYMPHOCYTE INCLUDING IT AND ASSOCIATED USE
|
|
SG11202008976YA
(en)
|
2018-04-02 |
2020-10-29 |
Nat Univ Singapore |
Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
|
|
US20210228629A1
(en)
*
|
2018-04-27 |
2021-07-29 |
Crispr Therapeutics Ag |
Anti-bcma car-t-cells for plasma cell depletion
|
|
GB201813178D0
(en)
*
|
2018-08-13 |
2018-09-26 |
Autolus Ltd |
Cell
|
|
US12486514B2
(en)
|
2018-08-29 |
2025-12-02 |
National University Of Singapore |
Method to specifically stimulate survival and expansion of genetically-modified immune cells
|
|
MX2021003435A
(es)
|
2018-09-28 |
2021-06-15 |
Massachusetts Inst Technology |
Moleculas inmunomoduladoras localizadas en el colageno y metodos de las mismas.
|
|
US20220267435A1
(en)
*
|
2018-10-03 |
2022-08-25 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Covalent adaptor synnotch and chimeric antigen receptors (cars) for programmable antigen-targeting
|
|
EP3632461A1
(en)
|
2018-10-05 |
2020-04-08 |
St. Anna Kinderkrebsforschung |
A group of chimeric antigen receptors (cars)
|
|
JP2022512594A
(ja)
*
|
2018-10-05 |
2022-02-07 |
ザンクト アンナ キンダークレプスフォルシュング |
キメラ抗原受容体（ｃａｒ）の群
|
|
CN113366479A
(zh)
|
2018-12-14 |
2021-09-07 |
蓝鸟生物公司 |
二聚化剂调节的免疫受体复合物
|
|
BR112021013173A2
(pt)
*
|
2019-01-04 |
2021-09-28 |
The University Of Chicago |
Sistemas e métodos para modular rna
|
|
KR20210137085A
(ko)
|
2019-03-05 |
2021-11-17 |
엔카르타, 인크. |
Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
|
|
KR20220004750A
(ko)
|
2019-05-04 |
2022-01-11 |
인히브릭스, 인크. |
Cd33 결합 폴리펩타이드 및 이의 용도
|
|
BR112021020999A2
(pt)
|
2019-05-04 |
2021-12-14 |
Inhibrx Inc |
Polipeptídeos de ligação à clec12a e usos dos mesmos
|
|
AU2020269268A1
(en)
|
2019-05-04 |
2021-11-11 |
Inhibrx Biosciences, Inc. |
CD123-binding polypeptides and uses thereof
|
|
CA3139512A1
(en)
*
|
2019-05-08 |
2020-11-12 |
Inhibrx, Inc. |
Cd123 targeted immunotherapies
|
|
EP3966251A4
(en)
*
|
2019-05-08 |
2023-05-10 |
Inhibrx, Inc. |
IMMUNOTHERAPIES TARGETED AGAINST CD33
|
|
EP3966249A4
(en)
*
|
2019-05-08 |
2023-05-10 |
2seventy bio, Inc. |
IMMUNOTHERAPIES TARGETED AGAINST CLL-1
|
|
US11642409B2
(en)
|
2019-06-26 |
2023-05-09 |
Massachusetts Insttute of Technology |
Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
|
|
WO2021061648A1
(en)
|
2019-09-23 |
2021-04-01 |
Massachusetts Institute Of Technology |
Methods and compositions for stimulation of endogenous t cell responses
|
|
JP2022551820A
(ja)
*
|
2019-10-15 |
2022-12-14 |
エフ．ホフマン－ラ ロシュ アーゲー |
細胞内または小胞内生体分子相互作用を検出するための人工膜貫通タンパク質
|
|
WO2021087183A1
(en)
*
|
2019-10-31 |
2021-05-06 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for chimeric antigen receptor targeting cancer cells
|
|
CA3164226A1
(en)
*
|
2019-12-11 |
2021-06-17 |
Cilag Gmbh International |
Multispecific binding molecules comprising ltbr and edb binding domains and uses thereof
|
|
US20210340524A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
|
|
US12433954B2
(en)
|
2020-05-01 |
2025-10-07 |
Massachusetts Institute Of Technology |
Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using amphiphilic ligand conjugates comprising CAR-targeting protein sequence motifs
|
|
EP4168438A4
(en)
*
|
2020-06-22 |
2024-07-10 |
Ramot at Tel-Aviv University Ltd. |
Multi subunit protein modules, cells expressing same and uses thereof
|
|
CA3172530A1
(en)
|
2021-02-25 |
2022-09-01 |
Spencer PARK |
Ror1 targeting chimeric antigen receptor
|
|
WO2023081715A1
(en)
|
2021-11-03 |
2023-05-11 |
Viracta Therapeutics, Inc. |
Combination of car t-cell therapy with btk inhibitors and methods of use thereof
|
|
CN120112309A
(zh)
*
|
2022-09-20 |
2025-06-06 |
丹娜-法伯癌症研究院 |
受体介导的胞吞作用用于治疗剂的靶向降解和递送
|
|
CN119638840A
(zh)
*
|
2023-09-15 |
2025-03-18 |
东莞市朋志生物科技有限公司 |
一种抗糖类抗原153的抗体及其应用
|